HOW HEALTHY ARE YOUR MARKET ACCESS PROGRAMS?
Pharmaceutical manufacturers invest countless resources to develop product distribution and patient access programs to maximize product success.
But eventually most programs will experience service disruptions, face unforeseen challenges, and receive negative feedback from stakeholders.
Why does that happen?
Just as patients are encouraged to get annual check-ups to assess their overall health even when they're feeling fine, manufacturers should assess the health of their market access programs to be proactive in managing potential operational, strategic, and budgetary issues.
This whitepaper is a guide for market access teams to perform check-ups on the programs that can most impact product success, including:
Wholesale and Specialty Distribution
HUB and Patient Support Services
Performance and Quality Management
Commercial Data Management
Register to Read the Whitepaper